PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

H&T Presspart granted European Patent for the eMDITM Connected Inhaler

H&T Presspart, the market leader in respiratory drug delivery components and devices, has been granted a European patent for its latest product, the eMDI connected metered-dose inhaler.
 
The patent granted focuses on an innovative design to allow the eMDI to validate if a patient has completed a successful actuation of the eMDI inhaler. This is the first granted patent out of a number of running patent applications for H&T Presspart’s eMDI, which further strengthens H&T Presspart’s IP position and demonstrates the strong commitment to the connected medical device market.
H&T Presspart’s eMDI is the first market-ready, fully embedded, connected metered-dose inhaler designed to wirelessly transmit data to the BreatheSmart® respiratory health platform from Cohero Health.
 
The eMDI powered by Cohero® is designed to track, remind and record the patient’s medication use using their smartphone and further enabling collaboration with their physician, caregivers and other stakeholders. The eMDI along with the BreatheSmart® platform enables pharmaceutical manufacturers to bring the best possible care to those with asthma and COPD.

H&T Presspart’s eMDI connected device

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026